Side-by-side comparison of AI visibility scores, market position, and capabilities
Fifth-largest US cable operator serving 1.3M+ customers in 22 rural and small-city markets; privately held competing with T-Mobile Home Internet for rural broadband subscribers.
Mediacom Communications is the fifth-largest cable television operator in the United States, serving 1.3+ million customers across 22 states — primarily operating in smaller cities and rural markets in the Midwest, Southeast, and West where larger cable operators like Comcast and Charter have limited presence. Founded in 1995 by Rocco Commisso in Middletown, New York, Mediacom is privately held and generates approximately $2 billion in annual revenue from residential and business broadband internet, cable TV, and phone service subscriptions.\n\nMediacom's service area strategy focuses on the "tier 2 and tier 3" markets — cities with 5,000 to 50,000 population where Comcast, Charter, and Cox have historically not expanded their fiber infrastructure. In these markets, Mediacom often faces less competition from fiber overbuilders (Google Fiber, municipal fiber networks) and competes primarily against DSL from regional telephone companies and fixed wireless internet from wireless carriers. The company has been upgrading its cable plant to DOCSIS 3.1 to deliver gigabit speeds and is investing in fiber-to-the-home expansion in select markets.\n\nIn 2025, Mediacom competes with rural telcos (Consolidated Communications, TDS Telecom), T-Mobile and Verizon Home Internet (fixed wireless broadband), and in some markets with new fiber overbuilders for its residential and business internet subscribers. The fixed wireless internet competition has intensified significantly — T-Mobile's Home Internet offers competitive speeds at lower prices than cable in many rural markets, representing the most significant competitive threat to Mediacom's subscriber base. Mediacom's 2025 strategy focuses on completing DOCSIS 4.0 and fiber upgrades to deliver superior speeds, protecting broadband subscriber share against fixed wireless competition, and growing business services revenue from local governments and enterprise customers in its markets.
Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.
AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.